An analysis of IL-36 signature genes and individuals with knockout mutations validates IL-36 as a psoriasis therapeutic target. (2017)

First Author: Mahil SK


No abstract provided

Bibliographic Information

Digital Object Identifier:

PubMed Identifier: 29021166

Publication URI:

Type: Journal Article/Review

Volume: 9

Parent Publication: Science translational medicine

Issue: 411

ISSN: 1946-6234